Award will support a 10,000-participant study comparing CyanVac’s PIV5-based intranasal vaccine candidate CVXGA with a commercial COVID-19 vaccine under BARDA’s Clinical Studies Network.

Strategic investment accelerates development of the first commercial-scale PHA facility, driving global adoption of eco-friendly plastics to mitigate environmental and health concerns.

The BioReady program allows municipalities like Athens-Clarke County to showcase biotech-zoned science parks, streamline permitting, build a robust infrastructure and identify biotech-friendly sites more effectively, making them an easy choice for industry.

The Athens Community Career Academy, part of the Clarke County School District, is ushering in a new era of education and community development with its innovative Biotechnology Track. Designed to meet the changing needs of the workforce in Athens, this program aims to prepare high school students for successful careers in the local biotech industry. The first of its kind in Georgia, the Biotechnology Track is a three-course pathway that equips students with the skills and knowledge to use living organisms and biological processes to solve problems and create useful products in fields like medicine, agriculture, and food science.

Meissner Corporation, an industry leader in advanced microfiltration and therapeutic manufacturing systems, will invest nearly $250 million in a new facility in Athens-Clarke County. The project will create more than 1,700 jobs over the next eight years.

The Global Center for Medical Innovation’s Sherry Farrugia and Athens Technical College’s Jeffrey Rapp, PhD are the recipients of the 2023 Industry Growth Awards for their impact on the life sciences industry in the state. The Industry Growth Awards are the highest honors bestowed each year by CGHI. 
Innovation Awards are presented to the department, institution, company or individuals who are forging new ground by thinking outside traditional paradigms to create some unique technology. Dalan Animal Health – Paenibacillus Larvae Bacterin Honeybee Vaccine,

A decades-long partnership between Georgia’s flagship university and a global leader in human and animal health has improved the lives of students, educators, researchers, farmers, livestock, pets and pet owners. And for UGA and Boehringer-Ingelheim, the work has only just begun.

Blue Lake Biotechnology, Inc., a clinical-stage biotechnology company developing intranasal vaccines using a proprietary parainfluenza virus 5 (PIV5)-based vector, announced preliminary interim data today from a phase 1 clinical trial of its BLB201 vaccine for prevention of severe respiratory syncytial virus (RSV)-associated disease (NCT05281263).

Athens Research and Technology, an established life sciences company near the University of Georgia was recently recognized as one of Georgia’s Exporters of the Year. ART manufacturers bio-medically relevant proteins for use in research and further manufacturing. In spite of supply chain issues and quarantines, ART remained committed to their clients worldwide ensuring that materials vital to research and product development where delivered on time. ART’s purified proteins are often used for antigen testing and in pharmaceutical research.

Dalan Animal Health, Inc., a biotech company focused on insect health, announced today that it will relocate its headquarters to Athens, Georgia. The company is anticipated to create 20 new jobs over the next five years.
The company aims to bring to market the world’s first honeybee vaccine to improve the health and productivity of honeybee colonies.

Governor Brian P. Kemp today announced that Boehringer Ingelheim, a global research-driven pharmaceutical development and manufacturing company based in Germany, will expand its Animal Health Global Innovation center in Athens, Georgia. The $57 million investment will increase laboratory space and bring additional research and development capabilities and activities, including 55 new positions, to the site.

Materials innovation company Cove’s partnership with PHA supplier RWDC will supply Cove with PHA for the production of the first water bottles made of biodegradable material. After an extensive, three-year research and development effort, during which Cove worked with a number of PHA producers, the company determined that RWDC has the most advanced technology and is the best-suited partner for aggressive growth.

Governor Brian P. Kemp today announced that biotechnology company RWDC Industries will invest $260 million in expanding its operations into Athens-Clarke County. This innovative development will create 200 jobs.

As ArunA Biomedical CEO Mark Sirgo tells it, his colleague Steve Stice, Ph.D., had been “throwing away the best part for years.” He’s referring to exosomes, a cellular component long thought of as the cell’s garbage removal system.